Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Biomarkers in bone disease / / Vinood B. Patel, Victor R. Preedy, editors
| Biomarkers in bone disease / / Vinood B. Patel, Victor R. Preedy, editors |
| Edizione | [1st ed. 2017.] |
| Pubbl/distr/stampa | [Place of publication not identified] : , : Springer, , [2017] |
| Descrizione fisica | 1 online resource (186 illus., 108 illus. in color. eReference.) |
| Disciplina | 616.71 |
| Collana | Biomarkers in disease |
| Soggetto topico | Bones - Diseases |
| ISBN | 94-007-7693-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Serum uric acid and biomarkers of lumbar spine bone mineral density -- Use of alkaline phosphatase (ALP) activity and disease severity to determine secular changes in bone disease as applied to Paget's disease of the bone -- Bone Turnover and Spinal Cord Injury -- Bone-related proteins as markers in vascular remodelling -- Serum Sclerostin as Biomarker in Osteogenesis Imperfecta -- Parathyroid Hormone (PTH) assays and applications to bone disease: Overview on methodology -- Registered microcomputed tomography data as a four dimensional imaging biomarker of bone formation and resorption -- Use of bone biomarkers after weight loss: Example of bariatric surgery -- Adiponectin as biomarker of osteoporosis -- Effect of statins on bone turnover markers -- Chitinases as biomarkers in bone studies -- Hormone relaxin as biomarker for bone health and disease -- Panoramic radiomorphometric indices of mandible: Biomarker for osteoporosis -- Hip Fracture Risk is Strongly Related to Circulating Levels of the Advanced Glycation End-product Carboxy-Methyl Lysine (CML) -- Effects of glucose on bone markers: Overview of current knowledge with focus on diabetes, glucose, and bone markers -- Traditional medicine and use of bone biomarkers -- Osteosarcoma Biomarkers discovery using "omics" approaches -- Creatine kinase as biomarker in osteogenesis imperfecta -- Ameloblastin as biomarker of bone -- Biomarker genes in autosomal dominant osteopetrosis type II (ADO II) -- Bone markers in Rett syndrome -- Bone Specific Alkaline Phosphatase and Exercise -- Bone turnover markers and glucocorticoid treatments -- Overview of biochemical markers of bone metabolism -- Biomarkers of natural radionuclides in bone and teeth -- Bone markers throughout sexual development: epidemiological significance and population-based findings -- Parathyroid hormone (PTH) and the relationship between PTH and bone health: structure, physiology, actions, and ethnicity -- Quantitative ultrasound as a biomarker tool in newborn infants for bone -- Bone biomarkers in gestational hypertension -- Bone biomarkers in intrauterine growth restriction -- Raman spectroscopy as a biomarker-investigative tool in bone metabolism -- Pentosidine as a biomarker for poor bone quality and elevated fracture risk -- Spine bone texture and the trabecular bone score (TBS) -- Bone biomarkers in HIV -- Bone Biomarkers Related to Osteoarthritis -- Dietary Soy Phytoestrogens and Biomarkers of Osteoporosis -- Utilisation and reference values of osteocalcin and procollagen type 1 n-propeptide -- Analysis of integrin alpha2beta1 (a2b1) expression as a biomarker of skeletal metastasis -- Circulating Sclerostin in Bone Sclerosing Disorders -- Pentraxin 3 as a bone biomarker -- Sirtuins as markers of bone disease: a focus on osteoarthritis and osteoporosis -- Tartarate resistant acid phosphatase as a biomarker of bone remodeling. . |
| Record Nr. | UNINA-9910484467803321 |
| [Place of publication not identified] : , : Springer, , [2017] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomarkers in diabetes / / edited by Vinood B. Patel and Victor R. Preedy
| Biomarkers in diabetes / / edited by Vinood B. Patel and Victor R. Preedy |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (1162 pages) |
| Disciplina | 610.28 |
| Collana | Biomarkers in Disease: Methods, Discoveries and Applications |
| Soggetto topico |
Biochemical markers
Diabetes - Diagnosis |
| ISBN | 3-031-08014-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- About the Editors -- Contributors -- Part I: General Aspects -- 1 Linking Variants of Hemoglobin A1C and Glycemic Status -- Introduction -- Overview of Genome-Wide Association Studies of HbA1c -- Functional Characterization of HbA1c-Associated Genetic Variants -- Glycemic-Related Genetic Variants -- Erythrocyte-Related Genetic Variants -- Unclassified Genetic Variants -- Erythrocyte-Related HbA1c Variants and Glycemic Status Screening -- G6PD: rs1050828 and rs76723693 -- HBB-rs334 -- G6PD-rs1050828 and HBB-rs334 -- Cumulative Effect of Erythrocyte-Related Genetic Variants -- Conclusion -- Applications to Other Diseases or Conditions -- Mini-Dictionary of Terms -- Key Facts of HbA1c -- Summary Points -- Reference -- 2 Treatment Regimes in Diabetes and Their Impact on Biomarkers -- Lipid Profile and T2DM -- Introduction to Lipids and T2DM -- The Relationship Between Obesity and Lipids -- The Relationship Between Lipids and T2DM -- Lipid Intermediates and Insulin Resistance -- Role of Exercise on Lipid Metabolism in T2DM -- Acute Effects of Exercise on Muscle Lipid Content -- Acute Effects of Exercise on Muscle Lipid Intermediates -- Chronic Effects of Exercise on Muscle Lipid Content -- Chronic Effects of Exercise on Muscle Lipid Intermediates -- Effect of Exercise on Liver Lipid Content -- Exercise Interventions and Classic Lipid Biomarkers -- Inflammatory Profile and T2DM -- Introduction to Inflammation and T2DM -- The Relationship Between Obesity and Inflammation -- The Relationship Between Inflammation and T2DM -- TNF-α and T2DM -- IL-6 and T2DM -- IL-1β and T2DM -- Anti-inflammatory Effects of Exercise -- Acute Effects of Exercise and Anti-inflammatory Mechanisms -- Chronic Effects of Exercise and Anti-inflammatory Mechanisms -- Exercise Interventions and Inflammatory Biomarkers.
Applications to Other Diseases or Conditions -- Conclusion -- Mini-Dictionary of Terms -- Key Facts on Exercise and the Lipid Profile -- Key Facts on Exercise and Inflammation -- Summary Points -- References -- Part II: Circulating and Body Fluid Biomarkers: Impact of Diabetes on Pathology -- 3 Resistin as a Biomarker and Applications to Prediabetes -- Introduction -- Diabetes -- Prediabetes: Definition and Related Diseases -- The Role of Adipokines at Energy Balance -- Resistin As a Biomarker at Different Types of Disease -- Resistin As a Biomarker in Cardiovascular Disorders -- Resistin As a Biomarker in Obesity -- Resistin As a Biomarker in Diabetes -- Resistin As a Biomarker in Cancer -- The Association Between Resistin and Prediabetes and Outcomes -- Conclusion -- Key Facts of Resistin -- Summary Points -- References -- 4 Altered Metabolome of Amino Acids Species: A Source of Signature Early Biomarkers of T2DM -- Introduction -- Diabetes Mellitus -- The Need for New Biomarkers for Diabetes -- Amino Acids in Metabolic Signaling and Insulin Resistance -- Altered Amino Acid Profiles in Insulin Resistance and Diabetes -- Amino Acids Metabolic Intermediates As Markers for Insulin Resistance and Diabetes -- Conclusions -- Applications to Prognosis, Other Diseases, or Conditions -- Mini Dictionary of Terms -- Key Facts of Amino acids -- Summary Points -- References -- 5 Components of the Purine Metabolism Pathways as Biomarkers for the Early Diagnosis of Diabetes -- Introduction -- Purine Metabolism -- Xanthine Oxidase -- Adenosine Metabolizing Enzymes, Inosine and Adenosine -- Inosine-5′-Monophosphate Dehydrogenase -- Uric Acid -- Conclusion -- Applications to Prognosis, Other Diseases or Conditions -- Mini-Dictionary of Terms -- Key Facts of Purine Enzymes and Related Metabolites -- Summary Points -- References. 6 Serpin A12 (Vaspin) as a Serine Protease Inhibitor -- Introduction -- Type 2 Diabetes and the Importance of Biomarkers -- Vaspin as a Diabetes Biomarker -- Biochemical Characterization -- Main Sources of Vaspin -- Vaspin and Anti-Inflammatory Effects -- Glucose Intolerance and Vaspin -- Insulin Role and Vaspin Action -- Circulating Vaspin Level, Type 2 Diabetes, and Obesity -- Metabolic Syndrome (MetS) and Vaspin -- Applications to Prognosis, Other Diseases, and Conditions -- Conclusion -- Mini-Dictionary of Terms -- Key Facts of Type 2 Diabetes -- Summary Points -- References -- 7 Advanced Glycation End Products in Diabetes -- Introduction -- Advanced Glycation End Products (AGEs) -- AGE Receptors -- Effects of AGEs -- AGE Measurements -- Effects of AGEs in Diabetes -- Nephropathy in Diabetes -- Cardiomyopathy and Arterial Alterations in Diabetes -- Neuropathy in Diabetes -- Retinopathy in Diabetes -- Cancer and Diabetes -- Cross Talk Between AGEs and Oxidative Stress in Diabetes -- AGEs in Other Diseases -- Applications to Other Diseases or Conditions -- Mini Dictionary of Terms -- Key Facts of Diabetes: Where Advanced Glycation End Products Is the Topic -- Summary Points -- References -- 8 Markers of Liver Function and Insulin Resistance -- Introduction -- Applications to Diagnosis -- Mini-Dictionary of Terms -- Summary Points (5-10) -- Markers of Liver Function and Insulin Resistance -- Visceral Fat and Insulin Resistance -- NAFLD, IR Y T2DM -- Hepatokines -- DPP4 (Dipeptidyl Peptidase-4) -- Pharmacological DPP-4 Inhibitors -- Fetuin A (AHSG) -- Fetuin B -- Selenoprotein P -- LECT-2 -- Hepassocin, Also Called Hepatocyte-Derived Fibrinogen-Related Protein 1, HPS, and HFREP1 -- Pigment Epithelium-Derived Factor -- Tsukushi (TSK) -- Conclusions -- References -- 9 Biological Markers of Insulin Sensitivity Links with Dietary Antioxidant. Introduction -- Applications to Diagnosis -- Mini Dictionary of Terms -- Key Facts of Insulin Sensitivity, Biomarkers, and Dietary Antioxidants -- Summary Points -- Markers of Liver Function and Insulin Resistance -- Insulin Sensitivity -- Adiponectin -- Adropin, Angiopoietin-lLike Protein 4 (ANGPTL4) -- DPP4, GLP-1 -- Fetuin-A and Fetuin-B -- FGF21 -- HMBG1, Myostatin -- Interleukins, Irisin, RBP4 -- Minerals in Insulin Resistance Sensitivity -- Calcium, Magnesium -- Chromiun, Selenium, Zinc -- Vitamins in Insulin Sensitivity -- Vitamin C, E -- Vitamin D, K, B -- Conclusions -- References -- 10 Serum Uric Acid and Metabolic Markers in Diabetes -- Introduction -- Metabolic Markers in Diabetes -- Uric Acid -- Uric Acid in Diabetes Pathophysiology -- Uric Acid as a Biomarker in Diabetes -- Serum Uric Acid as a Predictor of Diabetes Risk -- Serum Uric Acid, Blood Glucose Level, and HbA1c -- Uric Acid in Diabetic Complications -- Uric Acid in Macrovascular Complications -- Uric Acid in Microvascular Complications -- eGFR and Serum Uric Acid Levels -- Applications to Prognosis and Other Diseases or Conditions -- Applications to Prognosis -- Applications to Other Diseases or Conditions -- Mini-Dictionary of Terms -- Key Facts of Serum Uric Acid and Metabolic Markers in Diabetes: eGFR, HbA1c, and Beyond -- Key Facts of Uric Acid and Diabetes -- Key Facts of Uric Acid and Diabetic Complications -- Summary Points -- References -- 11 Urinary Interleukins and Kidney Damage in Diabetes -- Introduction -- Inflammation and Diabetic Kidney Disease -- Urinary Interleukins -- Interleukin 1 -- Interleukin 6 -- Interleukin 8 -- Interleukin 10 -- Interleukin 18 -- Potential Applications to Prognosis, Other Diseases, or Conditions -- Mini-dictionary of Terms -- Key Facts of Diabetes, Kidney Damage, and Urinary Interleukins -- Summary Points -- References. 12 Serum Homocysteine as a Biomarker in Diabetes -- Introduction -- Homocysteine and Its Role in the Body -- Biosynthesis and Metabolism of Homocysteine -- Factors Causing Hyperhomocysteinemia -- Diabetes Mellitus Cellular Metabolism Disturbance and Micronutrient Status in Diabetes Mellitus -- Hyperhomocysteinemia and Diabetes Mellitus -- Cognitive Dysfunction in Diabetes Mellitus -- Cognitive Function -- Factors That Affect Cognitive Function -- Hyperhomocysteinemia and Cognitive Function -- Compliance in Diabetes Management and Cognitive Dysfunction -- Applications to Prognosis -- Mini-Dictionary of Terms -- Key Facts of Serum Homocysteine as a Biomarker in Diabetes: Links with Variables Such as Cognition -- Summary Points -- References -- 13 3-Hydroxyisobutyrate (3-HIB): Features and Links as a Biological Marker in Diabetes -- Introduction -- BCAA Catabolism in Adipose Tissue -- 3-HIB in Interorgan Metabolic Crosstalk -- 3-HIB Reflects Hepatic Fatty Acid Oxidation -- Conclusion and Future Perspectives -- Applications to Prognosis, Other Diseases, or Conditions -- Mini-Dictionary of Terms -- Key Facts of Diabetes -- Summary Points -- References -- 14 Proteomic Biomarkers: What They Are and How Type 2 Diabetes Mellitus Has Similarities with Other Diseases -- Introduction -- Proteomic Biomarkers and Type 2 Diabetes Mellitus -- Proteomics in Type 2 Diabetes Mellitus Complications -- Diabetic Retinopathy -- Diabetic Kidney Disease -- Diabetic Neuropathy and Chronic Wounds -- Proteomics in Type 2 Diabetes Mellitus and Other Diseases -- Type 2 Diabetes Mellitus and Obesity -- Type 2 Diabetes Mellitus and Cardiovascular Diseases -- Type 2 Diabetes Mellitus and Metabolic Diseases -- Type 2 Diabetes Mellitus and Pancreatic Cancer -- Type 2 Diabetes Mellitus and Neurologic Disorders -- Conclusion -- Applications to Prognosis and Other Diseases or Conditions. Applications to Prognosis. |
| Record Nr. | UNINA-9910616369603321 |
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomarkers in liver disease / / Vinood B. Patel, Victor R. Preedy, editors
| Biomarkers in liver disease / / Vinood B. Patel, Victor R. Preedy, editors |
| Edizione | [1st ed. 2017.] |
| Pubbl/distr/stampa | Dordrecht, The Netherlands : , : Springer, , [2017] |
| Descrizione fisica | 1 online resource (162 illus., 110 illus. in color. eReference.) |
| Disciplina | 616.362 |
| Collana | Biomarkers in disease |
| Soggetto topico | Liver - Diseases |
| ISBN | 94-007-7675-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Liver biomarkers and their applications to nutritional interventions in animal studies -- AST-to-platelet ratio index (APRI) as marker in liver disease.-Inflammatory biomarkers in ascites -- Biomarkers for hepatocellular carcinoma in East Asia -- Liver disease and acylcarnitines as mechanistic biomarkers.-Type VI Collagen: Biological Functions and its Neo-epitope as Hepatic Fibrosis Biomarker -- Fibrinogen α-chain as a serum marker of liver disease -- Monocyte chemotactic protein-1 (cytokine, receptors,and gene polymorphisms) in hepatitis -- Biomarkers for Recurrence of Hepatocellular Carcinoma.-Graft-derived cell-free DNA as a biomarker in liver transplantation -- Serum sialic acid as a biomarker in liver disease -- CD133 and EpCAM as Biomarkers in Liver Diseases -- Traditional markers in liver disease -- Biomarkers of extracellular matrix remodeling in liver diseases -- Squamous Cell Carcinoma Antigen- Immunoglobulin M (SCCA-IgM) as biomarker in liver disease: biological aspects and clinical applications -- microRNA-155 and microRNA-196b in hepatitis C virus infection -- Immunological biomarkers in liver transplantation -- Phosphatidylethanol and alcohol use in liver disease patients -- Interaction of sialyltransferases, sialidases and sialic acids in liver diseases and applications to biomarker discovery -- Biomarkers to monitor graft function following liver transplantation -- YKL-40 as a biomarker of liver diseases -- Peripheral venous, portal venous, hepatic venous, arterial and intrahepatic cytokine levels as biomarkers and functional correlations -- Histological Biomarkers of Non-Alcoholic Fatty Liver Disease -- Vascular cell adhesion molecule-1 (vcam-1) expression in liver disease -- Bilirubin as a biomarker in liver disease -- Hydroxyproline as a biomarker in liver disease -- Genetic biomarkers of paracetamol-induced acute liver failure -- PNPLA3 polymorphism and Nonalcoholic Fatty Liver Disease -- Hepascore and it's application to liver disease -- Model for End-Stage Liver Disease (MELD) Score as a Biomarker -- Biomarkers in focus: Alanine Aminotransferase -- PTX3 as a biomarker of liver disease. |
| Record Nr. | UNINA-9910484161303321 |
| Dordrecht, The Netherlands : , : Springer, , [2017] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomarkers in nutrition / / Vinood B. Patel and Victor R. Preedy
| Biomarkers in nutrition / / Vinood B. Patel and Victor R. Preedy |
| Autore | Patel Vinood B. |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer International Publishing, , [2022] |
| Descrizione fisica | 1 online resource (1173 pages) |
| Disciplina | 610.28 |
| Collana | Biomarkers in Disease |
| Soggetto topico |
Biochemical markers
Biochemical markers - Evaluation Marcadors bioquímics Nutrició |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-031-07389-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910617306803321 |
Patel Vinood B.
|
||
| Cham, Switzerland : , : Springer International Publishing, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomarkers in Toxicology [[electronic resource] /] / edited by Vinood B. Patel, Victor R. Preedy, Rajkumar Rajendram
| Biomarkers in Toxicology [[electronic resource] /] / edited by Vinood B. Patel, Victor R. Preedy, Rajkumar Rajendram |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (1160 pages) |
| Disciplina | 610.28 |
| Collana | Biomarkers in Disease: Methods, Discoveries and Applications |
| Soggetto topico |
Biochemical markers
Toxicology Medicine—Research Biology—Research Pharmacology Forensic sciences Biomarkers Medical Toxicology Biomedical Research Forensic Science |
| ISBN | 3-031-07392-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Markers of liver toxicity and biomarkers -- Biomarkers of kidney toxicity. -Biomarkers of cardiac toxicity: microRNA and beyond.-Biomarkers of gastrointestinal toxicity -- Biomarkers of skin toxicity -- Skeletal muscle biomarkers in toxicity studies -- Bone markers of toxicity -- biochemical markers of brain damage -- DNA adducts as biomarkers of nutritional toxicity -- Biomarkers of pollution toxicity: measuring heavy metals in blood -- Challenge-comet assay: applications to toxicity -- Alkylation adducts of nucleic acids as a biomarkers .-TGx-DDI transcriptomic biomarker: Features and applications.-DNA biomarkers: an updated narrative -- CRISPR/Cas9 Whole-Genome Screens: applications to environmental pollutants.-Apoptotic biomarkers in toxicity studies -- 5'UTR methylation as a biomarkers: investigating volatile organics -- 5-Fluorouracil degradation rate and a biomarker of capecitabine toxicity -- Investigating the blood-brain barrier as a marker of toxicology -- Biomarkers of oxidative stress: investigating apigenin -- Histology as a biomarker in toxicity: applications to investigating Syzygium guineense -- Hair metabolomics and biomarker discovery .-Markers of hepatotoxicity using metabolomics: applications to MDMA, ecstasy -- 1H-NMR metabolomics and biomarkers of myotoxins -- Nanoparticle-induced toxicity and transcriptomics as a biomarker discovery platform -- Urine metabolomics and biomarker discovery.-microRNA profiling as a biomarker platform: carcinogens and beyond. |
| Record Nr. | UNINA-9910647783003321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomarkers in trauma, injury and critical care / / edited by Rajkumar Rajendram, Victor R. Preedy, and Vinood B. Patel
| Biomarkers in trauma, injury and critical care / / edited by Rajkumar Rajendram, Victor R. Preedy, and Vinood B. Patel |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2023] |
| Descrizione fisica | 1 online resource (1203 pages) |
| Disciplina | 371 |
| Collana | Biomarkers in disease |
| Soggetto topico | Life sciences |
| ISBN | 3-031-07395-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Biomarkers and outcomes: the example of traumatic brain injury -- Biomarkers in neurological injury: fibrinogen and beyond -- Biomarkers for liver injury: micro RNAS and beyond -- Biomarkers in muscle injury: proteomic and beyond -- Biomarkers in lung injury: -- Biomarkers and penetrating thoracic trauma -- Biomarkers in renal injury -- Biomarkers of heart muscle damage and injury: mRNA expression and beyond -- Biomarkers of burn severity -- Biomarkers and prognosis in sepsis: muscle mass and beyond -- Biomarkers of acute inflammation in polytrauma -- Electrolytes in critical care as a biomarker -- Critical care and 5'-Aminolevulinate synthase 2 (ALAS2) expression as a biomarker -- miRNAs as biomarkers of critically Ill patients -- C-Reactive protein and implications to the Neonatal Intensive Care Unit -- 129Xe magnetic resonance imaging (MRI) as a biomarker and implications for critical care -- Gas imaging of aeration and fractional ventilation as a biomarker in critical care -- Circulating PD-1/2B4 CD8+ T-cells patterns as biomarkers and the ICU -- Collagen and fibrotic biomarkers in critical care -- Biomarker mortality prediction model for sepsis in critical care: parsimonious modelling and beyond -- Acute kidney injury in critical care and biomarkers -- Platelet Function Assays in trauma -- Coagulation tests and fibrinogen concentrate in trauma -- Biomarkers and the time window-in trauma patients -- Inflammatory biomarkers in animal model of brain Injury. . |
| Record Nr. | UNINA-9910683348903321 |
| Cham, Switzerland : , : Springer, , [2023] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Coffee in health and disease prevention / / edited by Victor R. Preedy ; contributors Helena Abramovic [and one hundred sixty three others]
| Coffee in health and disease prevention / / edited by Victor R. Preedy ; contributors Helena Abramovic [and one hundred sixty three others] |
| Edizione | [1st edition] |
| Pubbl/distr/stampa | London, England : , : Academic Press, , 2015 |
| Descrizione fisica | 1 online resource (1080 p.) |
| Disciplina | 615.7 |
| Soggetto topico | Coffee - Physiological effect |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-12-416716-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
FrontCover; COFFEE IN HEALTHAND DISEASEPREVENTION; Contents; Contributors; Preface; SECTION 1: INTRODUCTORY AND GENERAL TEXT; SECTION 2: EFFECTS OF COFFEE CONSUMPTION; SECTION 3: EFFECTS OF SPECIFIC COMPOUNDS FOUND IN COFFEE; SECTION 4: ANALYSIS AND METHODS; Biography; SECTION 1 -INTRODUCTORYAND GENERAL TEXT; PART 1.1 -THE PLANT; CHAPTER 1 -The Coffee Plant and Beans: An Introduction; 1.1 THE PLANT; 1.2 GREEN COFFEE PRODUCTION; 1.3 SUMMARY POINTS; References; Chapter 2- Highlights in the History of Coffee Science Related to Health; 2.1 INTRODUCTION; 2.2 COFFEE, HEALTH, AND SCIENCE
2.3 MAIN BIOACTIVE SUBSTANCES IN COFFEE2.4 IMPLICATIONS OF THE AMOUNT CONSUMED; 2.5 COFFEE AND ASSOCIATED HABITS; 2.6 EFFECTS RELATED TO ORGANS AND DISEASES; 2.7 COFFEE AND NUTRITION; 2.8 CONCLUDING REMARKS; 2.9 SUMMARY POINTS; References; Chapter3 - Plant Biochemistry: Trigonelline Biosynthesis in Coffea arabica and Coffea canephora; 3.1 INTRODUCTION; 3.2 SECONDARY METABOLITES PRODUCED IN COFFEE PLANTS; 3.3 OCCURRENCE OF TRIGONELLINE; 3.4 BIOSYNTHESIS OF TRIGONELLINE; 3.5 DEGRADATION OF TRIGONELLINE; 3.6 PHYSIOLOGICAL ASPECTS OF TRIGONELLINE METABOLISM IN COFFEE; 3.7 SUMMARY POINTS ReferencesChapter4 - Coffea Genome Organization and Evolution; 4.1 INTRODUCTION; 4.2 GENOMIC DIVERGENCE; 4.3 GENETIC DIVERSITY BASED ON TRANSPOSABLE ELEMENTS; 4.4 SUMMARY POINTS; References; Chapter5 - Caffeine-free Species in the Genus Coffea; 5.1 INTRODUCTION; 5.2 CAFFEINE CONTENT, BOTANICAL CLASSIFICATION, AND GEOGRAPHICAL DISTRIBUTION OF THE SPECIES; 5.3 GENETIC CONTROL OF CAFFEINE BIOSYNTHESIS; 5.4 CAFFEINE CONTENT AND DURATION OF THE FLOWERING-FRUCTIFICATION PERIOD; 5.5 SUMMARY POINTS; References Chapter6 - Characterization of Coffee Genes Involved in Isoprenoid and Diterpene Metabolic Pathways6.1 INTRODUCTION; 6.2 OVERVIEW OF THE ISOPRENOID METABOLIC PATHWAY; 6.3 CHEMICAL COMPOSITION AND BIOCHEMICAL ANALYSIS OF DITERPENES; 6.4 REGULATORY ENZYMES AND CANDIDATE GENES INVOLVED IN ISOPRENOID AND DITERPENE BIOSYNTHESIS; 6.5 CONCLUSIONS; 6.6 SUMMARY POINTS; References; Chapter7 - Botanical Aspects of the Antioxidant System in Coffee; 7.1 INTRODUCTION; 7.2 CONCLUSIONS; References; Chapter8 - Coffee Industry in India: Production to Consumption-A Sustainable Enterprise; 8.1 INTRODUCTION 8.2 OVERVIEW OF INDIAN COFFEE INDUSTRY8.3 TRENDS IN COFFEE EXPORTS AND CONSUMPTION; 8.4 INDIAN COFFEES: QUALITY PERSPECTIVE; 8.5 HISTORY OF COFFEE CULTIVATION IN INDIA AND EARLY CULTIVATED VARIETIES; 8.6 UNIQUE FEATURES OF COFFEE CULTIVATION IN INDIA; 8.7 GENETIC RESOURCES AND DIVERSITY OF COFFEE GENE POOL; 8.8 COFFEE GERMPLASM IN INDIA; 8.9 MOLECULAR CHARACTERIZATION OF REPRESENTATIVE COFFEE GERMPLASM AVAILABLE IN INDIA; 8.10 COFFEE SPECIES ENDEMIC TO INDIA; 8.11 TAXONOMIC STATUS OF INDIGENOUS PSILANTHUS SPECIES COMPARED WITH COFFEA SPECIES 8.12 GROWTH HABIT AND AGRONOMIC TRAITS OF INTEREST OF INDIGENOUS COFFEE SPECIES |
| Record Nr. | UNINA-9910460247403321 |
| London, England : , : Academic Press, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Coffee in health and disease prevention / / edited by Victor R. Preedy ; contributors Helena Abramovic [and one hundred sixty three others]
| Coffee in health and disease prevention / / edited by Victor R. Preedy ; contributors Helena Abramovic [and one hundred sixty three others] |
| Edizione | [1st edition] |
| Pubbl/distr/stampa | London, England : , : Academic Press, , 2015 |
| Descrizione fisica | 1 online resource (1080 p.) |
| Disciplina | 615.7 |
| Soggetto topico | Coffee - Physiological effect |
| ISBN | 0-12-416716-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
FrontCover; COFFEE IN HEALTHAND DISEASEPREVENTION; Contents; Contributors; Preface; SECTION 1: INTRODUCTORY AND GENERAL TEXT; SECTION 2: EFFECTS OF COFFEE CONSUMPTION; SECTION 3: EFFECTS OF SPECIFIC COMPOUNDS FOUND IN COFFEE; SECTION 4: ANALYSIS AND METHODS; Biography; SECTION 1 -INTRODUCTORYAND GENERAL TEXT; PART 1.1 -THE PLANT; CHAPTER 1 -The Coffee Plant and Beans: An Introduction; 1.1 THE PLANT; 1.2 GREEN COFFEE PRODUCTION; 1.3 SUMMARY POINTS; References; Chapter 2- Highlights in the History of Coffee Science Related to Health; 2.1 INTRODUCTION; 2.2 COFFEE, HEALTH, AND SCIENCE
2.3 MAIN BIOACTIVE SUBSTANCES IN COFFEE2.4 IMPLICATIONS OF THE AMOUNT CONSUMED; 2.5 COFFEE AND ASSOCIATED HABITS; 2.6 EFFECTS RELATED TO ORGANS AND DISEASES; 2.7 COFFEE AND NUTRITION; 2.8 CONCLUDING REMARKS; 2.9 SUMMARY POINTS; References; Chapter3 - Plant Biochemistry: Trigonelline Biosynthesis in Coffea arabica and Coffea canephora; 3.1 INTRODUCTION; 3.2 SECONDARY METABOLITES PRODUCED IN COFFEE PLANTS; 3.3 OCCURRENCE OF TRIGONELLINE; 3.4 BIOSYNTHESIS OF TRIGONELLINE; 3.5 DEGRADATION OF TRIGONELLINE; 3.6 PHYSIOLOGICAL ASPECTS OF TRIGONELLINE METABOLISM IN COFFEE; 3.7 SUMMARY POINTS ReferencesChapter4 - Coffea Genome Organization and Evolution; 4.1 INTRODUCTION; 4.2 GENOMIC DIVERGENCE; 4.3 GENETIC DIVERSITY BASED ON TRANSPOSABLE ELEMENTS; 4.4 SUMMARY POINTS; References; Chapter5 - Caffeine-free Species in the Genus Coffea; 5.1 INTRODUCTION; 5.2 CAFFEINE CONTENT, BOTANICAL CLASSIFICATION, AND GEOGRAPHICAL DISTRIBUTION OF THE SPECIES; 5.3 GENETIC CONTROL OF CAFFEINE BIOSYNTHESIS; 5.4 CAFFEINE CONTENT AND DURATION OF THE FLOWERING-FRUCTIFICATION PERIOD; 5.5 SUMMARY POINTS; References Chapter6 - Characterization of Coffee Genes Involved in Isoprenoid and Diterpene Metabolic Pathways6.1 INTRODUCTION; 6.2 OVERVIEW OF THE ISOPRENOID METABOLIC PATHWAY; 6.3 CHEMICAL COMPOSITION AND BIOCHEMICAL ANALYSIS OF DITERPENES; 6.4 REGULATORY ENZYMES AND CANDIDATE GENES INVOLVED IN ISOPRENOID AND DITERPENE BIOSYNTHESIS; 6.5 CONCLUSIONS; 6.6 SUMMARY POINTS; References; Chapter7 - Botanical Aspects of the Antioxidant System in Coffee; 7.1 INTRODUCTION; 7.2 CONCLUSIONS; References; Chapter8 - Coffee Industry in India: Production to Consumption-A Sustainable Enterprise; 8.1 INTRODUCTION 8.2 OVERVIEW OF INDIAN COFFEE INDUSTRY8.3 TRENDS IN COFFEE EXPORTS AND CONSUMPTION; 8.4 INDIAN COFFEES: QUALITY PERSPECTIVE; 8.5 HISTORY OF COFFEE CULTIVATION IN INDIA AND EARLY CULTIVATED VARIETIES; 8.6 UNIQUE FEATURES OF COFFEE CULTIVATION IN INDIA; 8.7 GENETIC RESOURCES AND DIVERSITY OF COFFEE GENE POOL; 8.8 COFFEE GERMPLASM IN INDIA; 8.9 MOLECULAR CHARACTERIZATION OF REPRESENTATIVE COFFEE GERMPLASM AVAILABLE IN INDIA; 8.10 COFFEE SPECIES ENDEMIC TO INDIA; 8.11 TAXONOMIC STATUS OF INDIGENOUS PSILANTHUS SPECIES COMPARED WITH COFFEA SPECIES 8.12 GROWTH HABIT AND AGRONOMIC TRAITS OF INTEREST OF INDIGENOUS COFFEE SPECIES |
| Record Nr. | UNINA-9910787300103321 |
| London, England : , : Academic Press, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Coffee in health and disease prevention / / edited by Victor R. Preedy ; contributors Helena Abramovic [and one hundred sixty three others]
| Coffee in health and disease prevention / / edited by Victor R. Preedy ; contributors Helena Abramovic [and one hundred sixty three others] |
| Edizione | [1st edition] |
| Pubbl/distr/stampa | London, England : , : Academic Press, , 2015 |
| Descrizione fisica | 1 online resource (1080 p.) |
| Disciplina | 615.7 |
| Soggetto topico | Coffee - Physiological effect |
| ISBN | 0-12-416716-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
FrontCover; COFFEE IN HEALTHAND DISEASEPREVENTION; Contents; Contributors; Preface; SECTION 1: INTRODUCTORY AND GENERAL TEXT; SECTION 2: EFFECTS OF COFFEE CONSUMPTION; SECTION 3: EFFECTS OF SPECIFIC COMPOUNDS FOUND IN COFFEE; SECTION 4: ANALYSIS AND METHODS; Biography; SECTION 1 -INTRODUCTORYAND GENERAL TEXT; PART 1.1 -THE PLANT; CHAPTER 1 -The Coffee Plant and Beans: An Introduction; 1.1 THE PLANT; 1.2 GREEN COFFEE PRODUCTION; 1.3 SUMMARY POINTS; References; Chapter 2- Highlights in the History of Coffee Science Related to Health; 2.1 INTRODUCTION; 2.2 COFFEE, HEALTH, AND SCIENCE
2.3 MAIN BIOACTIVE SUBSTANCES IN COFFEE2.4 IMPLICATIONS OF THE AMOUNT CONSUMED; 2.5 COFFEE AND ASSOCIATED HABITS; 2.6 EFFECTS RELATED TO ORGANS AND DISEASES; 2.7 COFFEE AND NUTRITION; 2.8 CONCLUDING REMARKS; 2.9 SUMMARY POINTS; References; Chapter3 - Plant Biochemistry: Trigonelline Biosynthesis in Coffea arabica and Coffea canephora; 3.1 INTRODUCTION; 3.2 SECONDARY METABOLITES PRODUCED IN COFFEE PLANTS; 3.3 OCCURRENCE OF TRIGONELLINE; 3.4 BIOSYNTHESIS OF TRIGONELLINE; 3.5 DEGRADATION OF TRIGONELLINE; 3.6 PHYSIOLOGICAL ASPECTS OF TRIGONELLINE METABOLISM IN COFFEE; 3.7 SUMMARY POINTS ReferencesChapter4 - Coffea Genome Organization and Evolution; 4.1 INTRODUCTION; 4.2 GENOMIC DIVERGENCE; 4.3 GENETIC DIVERSITY BASED ON TRANSPOSABLE ELEMENTS; 4.4 SUMMARY POINTS; References; Chapter5 - Caffeine-free Species in the Genus Coffea; 5.1 INTRODUCTION; 5.2 CAFFEINE CONTENT, BOTANICAL CLASSIFICATION, AND GEOGRAPHICAL DISTRIBUTION OF THE SPECIES; 5.3 GENETIC CONTROL OF CAFFEINE BIOSYNTHESIS; 5.4 CAFFEINE CONTENT AND DURATION OF THE FLOWERING-FRUCTIFICATION PERIOD; 5.5 SUMMARY POINTS; References Chapter6 - Characterization of Coffee Genes Involved in Isoprenoid and Diterpene Metabolic Pathways6.1 INTRODUCTION; 6.2 OVERVIEW OF THE ISOPRENOID METABOLIC PATHWAY; 6.3 CHEMICAL COMPOSITION AND BIOCHEMICAL ANALYSIS OF DITERPENES; 6.4 REGULATORY ENZYMES AND CANDIDATE GENES INVOLVED IN ISOPRENOID AND DITERPENE BIOSYNTHESIS; 6.5 CONCLUSIONS; 6.6 SUMMARY POINTS; References; Chapter7 - Botanical Aspects of the Antioxidant System in Coffee; 7.1 INTRODUCTION; 7.2 CONCLUSIONS; References; Chapter8 - Coffee Industry in India: Production to Consumption-A Sustainable Enterprise; 8.1 INTRODUCTION 8.2 OVERVIEW OF INDIAN COFFEE INDUSTRY8.3 TRENDS IN COFFEE EXPORTS AND CONSUMPTION; 8.4 INDIAN COFFEES: QUALITY PERSPECTIVE; 8.5 HISTORY OF COFFEE CULTIVATION IN INDIA AND EARLY CULTIVATED VARIETIES; 8.6 UNIQUE FEATURES OF COFFEE CULTIVATION IN INDIA; 8.7 GENETIC RESOURCES AND DIVERSITY OF COFFEE GENE POOL; 8.8 COFFEE GERMPLASM IN INDIA; 8.9 MOLECULAR CHARACTERIZATION OF REPRESENTATIVE COFFEE GERMPLASM AVAILABLE IN INDIA; 8.10 COFFEE SPECIES ENDEMIC TO INDIA; 8.11 TAXONOMIC STATUS OF INDIGENOUS PSILANTHUS SPECIES COMPARED WITH COFFEA SPECIES 8.12 GROWTH HABIT AND AGRONOMIC TRAITS OF INTEREST OF INDIGENOUS COFFEE SPECIES |
| Record Nr. | UNINA-9910812534403321 |
| London, England : , : Academic Press, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Dairy in human health and disease across the lifespan / / edited by Ronald Ross Watson, Robert J. Collier, Victor R. Preedy
| Dairy in human health and disease across the lifespan / / edited by Ronald Ross Watson, Robert J. Collier, Victor R. Preedy |
| Pubbl/distr/stampa | London, England : , : Academic Press, , 2017 |
| Descrizione fisica | 1 online resource (474 pages) |
| Disciplina | 613.26 |
| Soggetto topico | Dairy products in human nutrition |
| ISBN | 0-12-809869-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910583367303321 |
| London, England : , : Academic Press, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
